Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$52.03 USD

52.03
731,989

+0.17 (0.33%)

Updated Aug 16, 2024 04:00 PM ET

After-Market: $52.04 +0.01 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (149 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

McKesson (MCK) Announces Availability of FDA-Cleared Drug for MCL

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for MCL.

Thermo Fisher (TMO) Rides on Strong End Markets, New Launches

Thermo Fisher's (TMO) newly-launched Gibco CTS DynaCellect Magnetic Separation System is helping customers advance their cell and gene therapy programs.

Charles River (CRL) Introduces Novel IgY-Based ELISA Kit

Charles River's (CRL) HCP-ELISA is built on its HCP-GAPex service, enhancing the efficiency and efficacy of HCP assay development.

ResMed's (RMD) Mask Sales Drive Growth, Margin Issue Lingers

ResMed (RMD) continues to see robust demand for its market-leading mask portfolio despite being faced with challenges related to lower new patient setups from a competitor recall.

Here's Why You Should Retain Walgreens Boots (WBA) For Now

Investors are optimistic about Walgreens Boots (WBA) on continued partnership growth and a strong focus on strategic execution.

Abbott (ABT) to Expand Vascular Device Line With New Buyout

Abbott's (ABT) latest deal will help gain access to Cardiovascular System's leading atherectomy device to treat vascular disease.

AMN Healthcare (AMN) to Post Q4 Earnings: What's in the Cards?

AMN Healthcare's (AMN) fourth-quarter results are likely to reflect soft demand across the majority of its segments.

Abbott (ABT) EPD Growth Continues Amid Macroeconomic Challenges

At Abbott (ABT), Medical Device sales growth is led by strong performance in Electrophysiology, Structural Heart and Diabetes Care.

BD's (BDX) Latest Combination Test Receives the FDA's EUA

BD's (BDX) new combination test is likely to significantly aid clinicians in treating patients in the current and future respiratory virus seasons.

AMN Healthcare Services (AMN) Dips More Than Broader Markets: What You Should Know

AMN Healthcare Services (AMN) closed the most recent trading day at $93.60, moving -1.84% from the previous trading session.

3 Reasons to Retain NextGen (NXGN) Stock in Your Portfolio

NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.

Should SPDR S&P 600 Small Cap ETF (SLY) Be on Your Investing Radar?

Style Box ETF report for SLY

LabCorp's (LH) New Launches, Planned Spinoff to Aid Growth

In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.

AMN or DOCS: Which Is the Better Value Stock Right Now?

AMN vs. DOCS: Which Stock Is the Better Value Option?

Is AMN Healthcare Services (AMN) Stock Outpacing Its Medical Peers This Year?

Here is how AMN Healthcare Services (AMN) and Sorrento Therapeutics (SRNE) have performed compared to their sector so far this year.

Hologic (HOLX) Q1 Earnings Beat Estimates, 2023 View Up

Lower COVID-19 assays sales and supply chain challenges related to semiconductor chips dent Hologic's (HOLX) top line in Q1.

Thermo Fisher (TMO) Q4 Earnings Beat Estimates, Margins Down

Robust year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments boost Thermo Fisher's (TMO) Q4 revenues.

Edwards Lifesciences (EW) Q4 Earnings Top, Margins Increase

Edwards Lifesciences (EW) continues to register strong momentum in TMTT, led by the continued adoption of the PASCAL platform in Europe.

Integer Holdings (ITGR) Announces Solid Preliminary Q4 Revenues

Integer Holdings' (ITGR) revenue growth in the fourth quarter is likely to have been boosted by continued strong customer demand for its products.

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Investors continue to be optimistic about Nevro (NVRO), owing to its R&D edge.

AMN Healthcare Services (AMN) Stock Moves -0.88%: What You Should Know

AMN Healthcare Services (AMN) closed the most recent trading day at $95.47, moving -0.88% from the previous trading session.

AMN Healthcare Services (AMN) Flat As Market Sinks: What You Should Know

AMN Healthcare Services (AMN) closed the most recent trading day at $96.75, making no change from the previous trading session.

Here's Why You Should Retain DaVita (DVA) Stock for Now

Investors remain optimistic about DaVita (DVA) due to the strength in its DaVita Kidney Care.

Intuitive Surgical (ISRG) Falls Following Q4 Earnings Miss

Intuitive Surgical's (ISRG) fourth-quarter results reflect healthy demand for procedures, partially offset by lower system sales and unfavorable currency. Procedure volume in China suffers.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.